Clal Finance Underwriting

Clal Finance Underwriting was a leading Israeli investment banking and financial services firm headquartered in Tel Aviv. As a subsidiary of Clal Finance, the company specialized in managing initial public offerings (IPOs), secondary offerings, and private placements, primarily on the Tel Aviv Stock Exchange. The firm was particularly recognized for its significant role in the Israeli life sciences and high-tech sectors, acting as a primary financier and underwriter for numerous biotechnology and medical device companies. Following a strategic restructuring of its parent company, Clal Insurance, the underwriting business was sold to its management and partners in 2013. It played a pivotal role in the growth of the Israeli biotech ecosystem by facilitating access to capital for emerging healthcare innovators.